Skip to main content

Table 3 Significant linear regression coefficients of stages of change predicting PSQ symptomatology at the end of therapy

From: Increasing the treatment motivation of patients with somatic symptom disorder: applying the URICA-S scale

      

95% CI

 
 

B

SE B

β

t

p

Lower bound

Upper bound

R2

Model 1: Maintenance t1

.49

 Constant

.06

.06

 

.92

.362

−.07

.18

 

 PSQ baseline

.61

.11

.52

5.68

<.001

.40

.83

 

 Maintenance t1

.05

.02

.31

3.33

<.001

.02

.08

 

Model 2: Maintenance t2

.43

 Constant

.03

.07

 

.33

.74

−.12

.17

 

 PSQ baseline

.67

.12

.57

5.60

<.001

.43

.91

 

 Maintenance t2

.04

.02

.24

2.35

.022

.006

.08

 

Model 3: Maintenance t3

.42

 Constant

.02

.08

 

.26

.79

−.15

.19

 

 PSQ baseline

.67

.14

.54

4.94

<.001

.40

.95

 

 Maintenance t3

.04

.02

.27

2.46

.017

.01

.08

 
  1. t1/t2/t3 = at baseline/after 8th therapy session/ end of therapy. Model 1 / Model 2 / Model 3 = significant stages of change predictors at baseline/8th/last therapy session for PSQ at the end of therapy.
  2. PSQ Perceived Stress Questionnaire